tiprankstipranks
Australian Clinical Labs Ltd (AU:ACL)
ASX:ACL
Australian Market

Australian Clinical Labs Ltd (ACL) Financial Statements

17 Followers

Australian Clinical Labs Ltd Financial Overview

Australian Clinical Labs Ltd's market cap is currently ―. The company's EPS TTM is AU$0.077; its P/E ratio is 28.05; and it has a dividend yield of 4.63%. Australian Clinical Labs Ltd is scheduled to report earnings on August 22, 2024, and the estimated EPS forecast is AU$0.10. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22
Income Statement-
Total Revenue-
Gross Profit-
EBIT-
EBITDA-
Net Income Common Stockholders-
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 26.37M
Total AssetsAU$ 628.04M
Total DebtAU$ 262.38M
Net DebtAU$ 236.00M
Total LiabilitiesAU$ 395.49M
Stockholders EquityAU$ 232.44M
Cash Flow-
Free Cash Flow-
Operating Cash Flow-
Investing Cash Flow-
Financing Cash Flow-
Currency in AUD

Australian Clinical Labs Ltd Earnings and Revenue History

Australian Clinical Labs Ltd Debt to Assets

Australian Clinical Labs Ltd Cash Flow

Australian Clinical Labs Ltd Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis